glp-1 for metabolic syndrome Why are agonists being used to treat patients with nonalcoholic fatty liver disease? What's Coming Next for GLP-1

My daughter just completed her 45 days at the Claudia Black Center and it was a life changing experience for her and the family

The trial enrolled adults living with obesity and without type 2 diabetes

Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats

It's available with a prescription for adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related health condition like high cholesterol or high blood pressure

Patients with existing kidney conditions should discuss the risks and benefits with their healthcare provider

As an oral form of semaglutide, it provides the same weight management benefits as the injection